oxamic acid has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, H; Li, J; Rao, H; Wang, S; Xu, J; Yu, Z | 1 |
| Chen, W; Hu, J; Hu, S; Huang, LY; Jiang, X; Wang, YM; Xiao, Y; Xu, GY; Zhang, HH; Zhou, YL | 1 |
| Baeza, I; Meza-Toledo, S; Nogueda-Torres, B; Serna, M; Wong, C; Wong-Baeza, C | 1 |
| Baeza, I; Chena, MA; Elizondo, S; Nogueda, B; Rodríguez-Páez, L; Wong, C | 1 |
| Cassady, CJ; O'Regan, MH; Phillis, JW | 1 |
| Marak, GE; Till, GO; Ward, PA | 1 |
| Buckner, CK; Carlson, RP; Chang, J; Daniel, WC; Forster, TJ; Hand, JM; Lewis, AJ; Sisenwine, SF; Tio, C; Undem, BJ | 1 |
| Johnson, HG; Sheridan, AQ | 1 |
8 other study(ies) available for oxamic acid and Disease Models, Animal
| Article | Year |
|---|---|
HMGB1 promotes HLF-1 proliferation and ECM production through activating HIF1-α-regulated aerobic glycolysis.
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Proliferation; Collagen Type I; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Glycolysis; HMGB1 Protein; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Male; Oxamic Acid; Pulmonary Fibrosis; Rats; Rats, Wistar; Up-Regulation | 2017 |
Promoted interaction of nuclear factor-κB with demethylated cystathionine-β-synthetase gene contributes to gastric hypersensitivity in diabetic rats.
Topics: Amino Acids; Analysis of Variance; Animals; Area Under Curve; Case-Control Studies; Chromatin Immunoprecipitation; CpG Islands; Cystathionine beta-Synthase; Diabetes Mellitus, Experimental; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Dose-Response Relationship, Drug; Electromyography; Enzyme Inhibitors; Female; Ganglia, Spinal; Hypersensitivity; Membrane Potentials; Methylation; Neoplasm Proteins; NF-kappa B; Nucleocytoplasmic Transport Proteins; Oxamic Acid; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Stomach Diseases; Sulfites; Up-Regulation | 2013 |
Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
Topics: Alcohol Oxidoreductases; Animals; Cell Line; Cell Survival; Chagas Disease; Disease Models, Animal; Esters; Isoenzymes; Male; Mice; Nifurtimox; Nitroimidazoles; Oxamic Acid; Prodrugs; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains.
Topics: Alcohol Oxidoreductases; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kinetics; Mice; Models, Chemical; NAD; Nifurtimox; Nitroimidazoles; Oxamic Acid; Species Specificity; Time Factors; Trypanocidal Agents; Trypanosoma cruzi; Trypanosomiasis | 2005 |
Further studies on the effects of topical lactate on amino acid efflux from the ischemic rat cortex.
Topics: Administration, Topical; Amino Acids; Animals; Brain Ischemia; Cardiovascular Physiological Phenomena; Cerebral Cortex; Disease Models, Animal; Drug Interactions; Electroencephalography; Energy Metabolism; Glucose; Lactic Acid; Male; Neurons; Neuroprotective Agents; Oxamic Acid; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Respiratory Physiological Phenomena | 2001 |
Xanthine oxidase generation of toxic oxygen metabolites in acute uveitis.
Topics: Animals; Disease Models, Animal; Drug Evaluation; Endophthalmitis; Oxamic Acid; Rats; Superoxides; Uveitis; Xanthine Oxidase | 1990 |
The development of Wy-41,195, an orally effective antiallergic drug in animal models.
Topics: Administration, Oral; Amino Acids; Animals; Asthma; Disease Models, Animal; Dogs; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Kinetics; Lung; Mast Cells; Oxamic Acid; Rats; Skin | 1986 |
The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
Topics: Amino Acids; Animals; Asthma; Calcium; Cromolyn Sodium; Disease Models, Animal; Drug Evaluation; Histamine H1 Antagonists; Humans; Macaca mulatta; Mast Cells; Nitriles; Oxamic Acid; Rats; Tromethamine | 1986 |